Cite

HARVARD Citation

    De Haan, R. et al. (n.d.). OC-0692: Phase 1 study of olaparib as radiosensitizer for locally advanced non-small cell lung cancer. Radiotherapy and oncology. pp. S386-S387. [Online]. 
  
Back to record